UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Mayo Clinic proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Costs | United States - epidemiology | Neoplasms - economics | Humans | Patient Participation | Patient Advocacy | Antineoplastic Agents - economics | Neoplasms - epidemiology | Prescription Fees | Neoplasms - drug therapy | Antimitotic agents | Cancer patients | Patient outcomes | Economic aspects | Dosage and administration | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 01/2008, Volume 26, Issue 3, pp. 354 - 360
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology | Tumors | Up-Regulation | Prognosis | Prospective Studies | Membrane Glycoproteins - metabolism | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Hyperplasia | Middle Aged | Male | Mouth Neoplasms - metabolism | Precancerous Conditions - metabolism | Immunoenzyme Techniques | Aged, 80 and over | Biomarkers, Tumor - metabolism | Mouth Neoplasms - pathology | Adult | Female | Precancerous Conditions - pathology | Aged | Neoplasm Staging | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 01/2013, Volume 73, Issue 2, pp. 571 - 582
Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Pneumology | Adenocarcinoma - pathology | Prognosis | Adenocarcinoma of Lung | Neoplasm Invasiveness | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Gene Knockdown Techniques | Adenocarcinoma - diagnosis | DNA Methylation | Neoplasm Metastasis | Adenocarcinoma - metabolism | Animals | Receptors, Interleukin-8B - metabolism | Receptors, Interleukin-8B - genetics | Cell Line, Tumor | Mice | Lung Neoplasms - diagnosis | Smoking | Index Medicus | lung cancer | chemokine | metastasis | prognosis | CXCR2
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 07/2013, Volume 73, Issue 13, pp. 4028 - 4038
Life Sciences & Biomedicine | Oncology | Science & Technology | Toxicology | Pharmacology. Drug treatments | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tobacco, tobacco smoking | Tumors | Pneumology | Lung Neoplasms - genetics | Genome-Wide Association Study | Carcinoma, Non-Small-Cell Lung - genetics | Lung Neoplasms - mortality | Genes, Neoplasm | Humans | Kaplan-Meier Estimate | Polymorphism, Single Nucleotide | Quantitative Trait Loci | Carcinoma, Non-Small-Cell Lung - mortality | Smoking | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2005, Volume 23, Issue 24, pp. 5578 - 5587
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Otorhinolaryngology (head neck, general aspects and miscellaneous) | Tumors | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Drug Administration Schedule | Head and Neck Neoplasms - drug therapy | Logistic Models | Treatment Outcome | Disease Progression | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 07/2014, Volume 20, Issue 14, pp. 3849 - 3861
Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Pneumology | Lung Neoplasms - drug therapy | Up-Regulation | Adenocarcinoma - pathology | Cell Proliferation | Polycomb Repressive Complex 2 - genetics | Adenocarcinoma of Lung | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | MicroRNAs - metabolism | Molecular Targeted Therapy | Adenocarcinoma - metabolism | Female | Antineoplastic Agents - pharmacology | Signal Transduction | Kaplan-Meier Estimate | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Adenosine - pharmacology | Cisplatin - pharmacology | Adenocarcinoma - drug therapy | Enhancer of Zeste Homolog 2 Protein | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Adenosine - analogs & derivatives | Cell Line, Tumor | MicroRNAs - genetics | Carboplatin - pharmacology | Polycomb Repressive Complex 2 - metabolism | Vascular Endothelial Growth Factor A - physiology | Adenocarcinoma - mortality | Index Medicus | VEGFR-2 pathway | DZNep | NSCLC | VEGF | EZH2
Journal Article
Modern pathology, ISSN 0893-3952, 06/2018, Volume 31, Issue 6, pp. 947 - 955
Life Sciences & Biomedicine | Pathology | Science & Technology | Adenocarcinoma | Squamous cell carcinoma | Small cell lung carcinoma | Mesenchyme | PD-1 protein | Lung cancer | Non-small cell lung carcinoma | Lung carcinoma | Gene expression | Ribonucleic acid--RNA | Immunotherapy | Microenvironments | Tumors | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 07/2019, Volume 10, Issue 1, pp. 2978 - 10
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - genetics | Lung - pathology | Adenocarcinoma of Lung - pathology | Humans | Middle Aged | Carcinogenesis - genetics | Lung Neoplasms - pathology | Male | Precancerous Conditions - genetics | Whole Exome Sequencing | Hyperplasia - pathology | Adenocarcinoma of Lung - genetics | Hyperplasia - genetics | Aged, 80 and over | Female | Precancerous Conditions - pathology | Aged | Evolution, Molecular | Adenocarcinoma | Carcinogens | Transformation | Lung nodules | Invasiveness | Hyperplasia | Evolution | Nucleotides | Mutation | Carcinogenesis | Preneoplasia | Nodules | Index Medicus | Non-small-cell lung cancer | Cancer genomics
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2002, Volume 20, Issue 18, pp. 3815 - 3825
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Lung Neoplasms - drug therapy | Enzyme Inhibitors - blood | Humans | Middle Aged | Quinazolines - pharmacokinetics | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Dose-Response Relationship, Drug | Enzyme Inhibitors - pharmacokinetics | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Carcinoma, Non-Small-Cell Lung - pathology | Enzyme Inhibitors - adverse effects | Skin Diseases - chemically induced | Drug Administration Schedule | Administration, Oral | Head and Neck Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Quinazolines - blood | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Maximum Tolerated Dose | Quinazolines - therapeutic use | Quinazolines - adverse effects | Antineoplastic Agents - blood | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Neoplasms - pathology | Gastrointestinal Diseases - chemically induced | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2001, Volume 19, Issue 6, pp. 1830 - 1838
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Caffeine - administration & dosage | Tea - therapeutic use | Administration, Oral | Humans | Middle Aged | Caffeine - adverse effects | Tea - adverse effects | Male | Neoplasms - drug therapy | Dose-Response Relationship, Drug | Drugs, Chinese Herbal - pharmacokinetics | Caffeine - pharmacology | Adult | Female | Aged | Phytotherapy | Neoplasms - pathology | Pharmacokinetics | Drugs, Chinese Herbal - therapeutic use | Drugs, Chinese Herbal - adverse effects | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 09/2016, Volume 7, Issue 1, pp. 12961 - 12961
Journal Article